Abstract
Serratia marcescens is an aerobic, gram-negative bacillus of the Enterobacteriaceae family that exists as a saprophyte in soil and environmental water sources. This bacterium colonizes the gastrointestinal, urinary, and respiratory tracts of humans and was long considered benign until the 1950s, when it was found to cause nosocomial infections in debilitated patients [1]. In the hospital setting, S. marcescens may contaminate saline bottles, intravenous solutions, hand lotions, and even disinfectants [1]. In debilitated and immunocompromised individuals, S. marcescens causes a wide variety of infections, including chronic osteomyelitis, septic arthritis, endocarditis, and meningitis [1–4]. In immunocompetent individuals, S. marcescens infections are uncommon and those involving the skin, soft tissue, and bone of the upper extremity are extremely rare. While acute osteomyelitis in the upper extremity has been observed in intravenous drug-abusing (IVDA) individuals, this condition has not been reported in healthy, non-IVDA individuals. Since S. marcescens is frequently multidrug-resistant, any infection with this bacterium is best treated with thirdor fourth-generation cephalosporins.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.